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ABSTRACT
Objectives: To evaluate the Nordic Patient
Experiences Questionnaire (NORPEQ) for data quality,
reliability and validity following surveys of patients in
Finland, Norway, Sweden and the Faroe Islands.
Design, methods and participants: The NORPEQ
was mailed to 500 patients randomly selected after
receiving inpatient treatment in Finland, Norway and
Sweden. The NORPEQ was also included in a national
survey in Norway and in the Faroe Islands.
Dimensionality was assessed using principal
component analysis and internal consistency by item-
total correlation and Cronbach’s a. Construct validity
was assessed by correlating NORPEQ scores with
variables known to be related to patient experiences.
Setting: Somatic hospitals in Finland, Faroe Islands,
Norway and Sweden.
Primary and secondary outcome measures: Item
missing, internal consistency reliability and construct
validity.
Results: Response rates ranged from 45.8% in
Norway to 84% for Sweden. Levels of missing data
were low for all items across the surveys. Principal
component analysis identiﬁed one component with six
experiences items. Mean NORPEQ scores ranged from
74 to 79 on the 0e100 scale, where 100 represents the
best possible experiences. Cronbach’s a ranged from
0.84 in Finland to 0.88 in Sweden.
Conclusions: The NORPEQ is a brief measure of
patient experiences that covers important aspects
of the healthcare encounter. It shows good evidence of
reliability and validity.
Practice implications: The NORPEQ instrument is
recommended for cross-national comparisons of
healthcare experiences for the four Nordic countries.
INTRODUCTION
The literature relating to the development
and testing of healthcare quality indicators
that assess patient experiences and satisfac-
tion is extensive.
1 2 Such indicators have
gained increasing importance following the
work of international organisations, such as
the Organisation for Economic Cooperation
and Development and the WHO, which have
emphasised the importance of the patient’s
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ARTICLE SUMMARY
Article focus
- The NORPEQ was designed to include a core set
of questions covering the most important
aspects of patient experiences that can be used
cross-nationally and alongside existing longer-
form national survey questionnaires.
- The aim of this study was to evaluate the
psychometric properties of NORPEQ in four
Nordic countries.
Key messages
- On the basis of a rigorous process of question-
naire development and evaluation including
forwardebackwards translation, levels of
missing data analysis, dimensionality, internal
and construct validity, the NORPEQ shows good
evidence of reliability and validity.
- The NORPEQ instrument is recommended for
cross-national comparisons of healthcare expe-
riences in the Nordic countries.
Strengths and limitations of this study
- The NORPEQ includes what are evaluated to be
the most important aspects of experiences for
patients. Levels of missing data were generally
very low across countries indicating the accept-
ability of the questionnaire.
- The NORPEQ was tested in four countries, and
there is good evidence for the cross-cultural
equivalence of the questionnaire.
- Results were based on pilot surveys in two
countries and should be further evaluated
following national surveys. Psychometric prop-
erties of the NORPEQ should also be tested in
Denmark and Iceland.
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Open Access Researchperspective by capturing patients’ experiences or satis-
faction in the evaluation of the quality of healthcare
delivery.
2e4 Much of this work has been at the local level
in relation to local providers, but national governments
require comparisons of providers.
12
All the Nordic countries have a history of measuring
patient experiences and patient satisfaction. The patient
groups surveyed, survey methodology and questionnaire
content have however differed. In Finland, the National
Institute for Health and Welfare (THL) questionnaire
has been used in different surveys,
5 but there has not
been a national patient experiences survey. In Norway,
national patient experience surveys have included
a variety of patient groups, including somatic inpatients,
6
outpatients,
6e8 psychiatric inpatients and outpatients,
7
and parents of paediatric patients.
9 In Denmark,
national patient experience surveys have been
conducted for many years, both among psychiatric and
somatic patients.
2 In Sweden, smaller scale studies have
been conducted with the Picker Patient Experience
Questionnaire,
10 and since 2009, the Swedish Associa-
tion of Local Authorities and Regions in Sweden has
conducted regular national surveys of users of primary
care services and among somatic and psychiatric inpa-
tients and outpatients. The Faroe Islands national
patient experience surveys were conducted in 2007 and
2010. Iceland has conducted national surveys of health-
care providers in 2002 and 2005.
2
The Nordic Council of Ministers initiated a cross-
national collaboration to develop a set of quality indica-
tors, including patient experiences, for measuring the
quality of the health services across the Nordic countries.
The work follows the Organisation for Economic Coop-
eration and Development’s conceptual framework in
which one of the core healthcare quality indicators is
patient-centeredness.
11 The similarities of the healthcare
systems within the Nordic countries make them well
suited for cross-national comparisons; care is virtually free
at the point of use, governments use monetary incentives
and various directives to inﬂuence the priorities of service
producers and accountability for service provision is
delegated to local authorities.
12 During the past decade,
the Nordic countries have increasingly presented infor-
mation regarding the performance of healthcare
providers. Public reports and internet sites such as the
‘Free Hospital Choice’ in Norway (http://www.frittsyke-
husvalg.no) and the ‘National Patient Questionnaire’ in
Sweden (http://www.skl.se/nationellpatientenkat) have
published results of surveys of patient experiences, the
intentions being quality improvement and public
accountability. Such information can also provide a basis
for cross-national comparisons.
21 3Cross-national
comparisons of patient experiences in the Nordic coun-
tries provide information about quality of healthcare,
which may inform the Nordic citizens, patients, politicians
and leaders and healthcare personnel thereby promoting
a common understanding of factors relating to healthcare
quality across the Nordic countries.
Although the CAHPS group has applied the CAPHS-
questionnaire across Spanish- and English-speaking
inpatients in the USA,
14 previous cross-national studies of
patient experiences have not demonstrated that the
questionnaires perform in the same manner cross-
nationally.
13 This makes it difﬁcult to determine to what
extent any differences in patient evaluations are attribut-
able to differences in healthcare quality or questionnaire
performance across countries. Hence, the importance of
adequate reporting of questionnaire development and
survey methodology has been emphasised.
21 11 5It is
important to account for cultural and demographic
differences, health problems and potential translation
problems in cross-national studies of patient experi-
ences.
2 Many healthcare quality indicators have been
studied at the local level with local providers, but national
governments require comparisons of providers.
21 1
The NORPEQ was designed to include a core set of
questions covering the most important aspects of inpa-
tient experiences that can be used for cross-national
comparison of inpatient experiences alongside existing
longer-form national survey questionnaires.
13 16 This
article describes the cross-national questionnaire devel-
opment based on surveys undertaken among hospital
inpatients in Finland, Norway, Sweden and Faroe Islands.
Following a rigorous process of questionnaire develop-
ment including forwardebackwards translation, the
NORPEQ questionnaire was assessed for levels of missing
data, reliability and validity in the four countries. The
development of NORPEQ followed recommended criteria
including forwardebackwards translation necessary for
a questionnaire that is to be used cross-nationally.
21 7
METHODS
NORPEQ development
The appropriateness of health quality indicators for
benchmarking and other aspects of quality improvement
is dependent on their reliability and validity,
11 18
and criteria for their evaluation have been recom-
mended.
3461 11 9 e21 These criteria were applied in the
development of the eight-item NORPEQ, which was
translated into English by two professional translators
(online appendix 1). Development followed a literature
review of existing questionnaires and consultation with
experts within the ﬁeld of patient experiences in three
face-to-face meetings. In the ﬁrst of these meetings, three
main considerations guiding the development of the
questionnaire were decided. First, the questionnaire
should include the most important aspects of patient
experiences following a literature review relevant to
patients across the Nordic countries. Second, the ques-
tionnaire should be brief so that the questions can
supplement existing surveys. Third, the questionnaire
should be developed in Norwegian and translated into
the other Nordic languages using the forwardebackwards
methodology.
13
The content of questionnaires used in surveys was
assessed for appropriateness, and patient involvement in
2 Skudal KE, Garratt AM, Eriksson B, et al. BMJ Open 2012;2:e000864. doi:10.1136/bmjopen-2012-000864
Cross-national comparison of data quality and validity of the NORPEQ instrumentthis process was designed to lend the NORPEQ content
validity. Analysis of themes and items in existing
NORPEQs revealed that the content of the question-
naires was fairly similar,
13 16 but that there was some
variation in question formulation and the choice of
scaling. The analysis was based on the most widely used
questionnaires in the Nordic countries,
13 16 which
included the national patient experience survey in
Denmark,
22 a 20-item measure of patient experience in
Finland,
5 a short form of the Quality from the Patient’s
Perspective questionnaire on Iceland,
23 the Patient
Experiences Questionnaire in Norway
6 and the Picker
survey in Sweden.
10 Furthermore, the review found that
patient experiences with health personnel including
whether the doctors were understandable, doctors’ and
nurses’ professional skills, nursing care, whether the
doctors and nurses were interested in the patients
problems and information related to tests are the most
important aspects of patients experiences.
13 16
Six of the eight NORPEQ items sum to produce an
overall scale from 0 to 100, where 100 is the best possible
experience of care. If respondents had missing values on
more than half of the items, mean scores were imputed.
The NORPEQ is designed to be routinely used alongside
longer-form instruments in Nordic and international
patient surveys.
9 13 18 24
The NORPEQ was tested by means of cognitive inter-
views with six patients. A Norwegian pilot survey of 500
patients receiving inpatient care at a large University
hospital found to have evidence for data quality, unidi-
mensionality, internal and testeretest reliability and
construct validity.
13
To ensure valid comparison across countries, ques-
tionnaires must demonstrate cross-cultural equivalence.
2
The NORPEQ questionnaire was developed in Norwe-
gian for translation into the other Nordic languages
using methods that adhere to minimum standards
recommended for translation of patient questionnaires,
including the forwardsebackwards methodology.
14 25 26
The questionnaire was translated into Danish, Finnish
and Swedish by two forward translators fairly acquainted
with the area and with some experience in health-related
research. Emphasis was put on conceptual rather than
literal translation. The backward translators were
Norwegians who were not familiar with the original
version. The Faroese version went through
forwardebackward translation from Danish to Faroese
and back to Danish. This was because Faroese speak
Danish, which is taught at school, and no one from the
research group was able to translate from Norwegian to
Faroese. Again, this included independent forward and
backward translators to ensure that the Faroese ques-
tionnaire was conceptually similar to the Danish version.
The Norwegian researchers assessed the forwardeback-
wards translations following discussions with those
responsible in the different countries, and it was agreed
that the instructions and questions had retained their
original meaning.
The approved translations were then tested by means
of cognitive interviews with six patients in Finland (n¼6)
Sweden (n¼11) and the Faroe Islands (n¼27). Patients
were asked whether they had omitted any questions, if
any questions were difﬁcult or too similar, if questions
were acceptable and relevant and if they had any other
problems with completion.
Data collection
In October and November 2009, 500 patients were
randomly selected from adult inpatients at one Univer-
sity hospital in Finland were sent a questionnaire. Postal
reminders were sent 3 weeks after the ﬁrst questionnaire.
Five hundred patients were randomly selected from
adult inpatients at one Swedish University hospital
within a 3-week period in FebruaryeMarch 2009. Two
postal reminders were sent to non-respondents at 1 and
3 weeks. The Norwegian national survey included 24141
patients randomly selected among patients discharged
from 63 hospitals in a 3-month period in 2006. About
a week later, a random sample of 270 respondents was
asked to complete an identical second questionnaire for
purposes of assessing testeretest reliability. The Faroe
Islands has only 50000 inhabitants and hence a large
pilot of the NORPEQ was not possible. Instead the
NORPEQ was applied alongside a national patient
experience survey. In May 2010, 892 inpatients were
discharged from three different hospitals on the Faroe
Islands, and these patients were mailed a questionnaire:
six patients were not eligible. One postal reminder was
sent 3 weeks later to non-respondents.
Statistical analysis
Questionnaire evaluation followed recommendations
relating to measures of patient satisfaction and ques-
tionnaire development more generally.
19 20 Items were
assessed for levels of missing data. Principal component
analysis (PCA) with varimax rotation was used to assess
the underlying dimensionality of the six items measuring
patient experiences.
27 28 Following previous ﬁndings,
13 it
was expected that these items would be unidimensional.
Internal consistency was assessed using item-total corre-
lation and Cronbach’s a. The former measures the
association between the item and the remainder of its
scale, the latter determines the overall correlation
between items within a scale.
13 In the national Norwe-
gian survey, testeretest reliability was assessed by the
intraclass correlation coefﬁcient.
Construct validity assesses the extent to which a ques-
tionnaire measures what it is intended and is assessed
through comparisons with variables that following
empirical and theoretical considerations have expected
associations with patient experiences or satisfaction.
20
Research including systematic reviews has found that
patient experiences and satisfaction are associated
with general satisfaction, perceptions of incorrect treat-
ment,
91 32 4health status, health outcomes, fulﬁlment of
expectations.
161 31 82 42 9We used responses to ﬁve
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Cross-national comparison of data quality and validity of the NORPEQ instrumentadditional items to assess construct validity of the
NORPEQ scores including the two items relating to
general satisfaction and incorrect treatment that have
been widely used in Nordic and international research
and items relating to general health,
91 01 32 4changes in
general health and physical health compared with
before admission, and fulﬁlment of expectations. These
items all have 5-point descriptive scales. For an overview
of stages in the development and evaluation of the
NORPEQ instrument see Table 1.
RESULTS
NORPEQ development
Only minor changes were made to the questionnaire on
the basis of the forwardebackward translations. The
results of cognitive interviews showed that the eight items
were acceptable, relevant and understandable to Norwe-
gian and Swedish inpatients. One challenge related to the
use of the term ‘health personnel’, which in Norwegian
includes nurses and licensed practice nurses, whereas in
other countries, nurses comprise other groups or they do
not have a corresponding concept. While there were no
problems for the other patient groups, some Finnish
patients found the item about whether doctors and health
personnel were interested in patient’s problem difﬁcult
because it asked about two occupational groups. However,
the majority of informants in Finland did not rate the
question as difﬁcult, and most found it relevant with
appropriate response categories. Therefore, no changes
to the NORPEQ were made following cognitive interviews
in Finland, Norway and Sweden. Several patients from the
Faroe Islands found the question relating to incorrect
treatment difﬁcult to understand, and hence, the ques-
tion was reformulated.
Data collection
Table 2 shows the response rate and respondent and
non-respondent characteristics for each country. Of 496
eligible patients, 383 (77.2%) responded to the Finnish
survey, and in the Swedish survey, 412 (84%) patients
responded. Of the 24141 patients included in the
Norwegian national survey, 11079 (45.8%) responded.
For the Faroe Islands, 551 (62.2%) responded.
In Finland, the respondents’ mean age was 59.1
(SD¼17.6) years and 51.7% were women. Respondents
were on average approximately 9 years older than non-
respondents, which was statistically signiﬁcant. Respon-
dents in Sweden were on average approximately 8 years
older, which was statistically signiﬁcant. In the Norwe-
gian national survey, the respondents’ mean age was
60.35 (SD 16.97) years and 53.2% were women (table 2).
There were a signiﬁcantly slightly greater proportion of
female respondents. Compared with non-respondents,
respondents were also signiﬁcantly more likely to be
admitted in an emergency and have 0.47 fewer days in
hospital. For the Faroe Islands, the respondents’ mean
age was 57.0 (23.6) years and 47.7% were women.
Statistical analysis
Missing data for the six NORPEQ items ranged from
0.5% to 3.9% across the three smaller surveys in Finland,
Norway and Sweden (table 2). For the Faroe Islands, the
level of missing data varied between 6.7% and 10%.
Incorrect treatment had the highest level of missing data
for all surveys, the only exception was Norway where
general satisfaction for the national survey had the
highest level of missing data. Item means for the four
surveys were generally skewed towards positive experi-
ences of care ranging from 3.7 to 4.4 on the 1e5 scale.
The mean ranking of items was very similar across the
surveys. Patients had the poorest experiences on the two
items information relating to tests or health personnel
being interested. Patients had the best experiences with
nursing care.
Results of PCA and measures of internal consistency are
shown in table 3. The Finnish data gave two components,
with eigenvalues of 3.38 and 1.02. One component was
found for the Swedish, Norwegian national and for the
Faroese data with eigenvalues of 3.82, 3.68 and 3.62,
respectively. Given the relatively low value for the second
component found for the Finnish data that just meets the
criterion of 1.0, a single component that comprised all six
items was accepted. The six items had high component
loadings between 0.70 and 0.82 on this single component.
The component loadings had a similar pattern across the
different countries with the items ‘health personnel
interested in health problem’ and ‘information on tests’
generally having the highest loadings and ‘nursing care’
and ‘doctors understandable’ generally having the lowest
loadings. Item-total correlations for the six NORPEQ
items were acceptable and ranged from 0.53 to 0.80.
Cronbach’s a for the six NORPEQ items ranged
from 0.84 to 0.88 for Finland and the Faroe Islands,
respectively.
Of 270 randomly selected Norwegian patients asked to
take part in the testeretest survey in the national
Norwegian survey, 196 (72.6%) returned a second
questionnaire. The intraclass correlations ranged from
0.68 to 0.73 for the items relating to information on test
and nurses’ professional skills, respectively. The intra-
class correlation for the NORPEQ scores was 0.85, which
is considered acceptable for group comparisons.
9 19
Table 1 Stages in the development and evaluation of the
NORPEQ
1 Item derivation Literature review,
Nordic surveys,
expert consensus
2 Translation Forwardsebackwards
3 Patient interviews Cognitive testing
4 Pilot survey Data qualitydmissing data,
response distribution
5 Main survey Dimensionality, internal
consistency, testeretest
reliability, construct validity
NORPEQ, Nordic Patient Experiences Questionnaire.
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Cross-national comparison of data quality and validity of the NORPEQ instrumentTable 4 shows that the NORPEQ scores for the four
countries were skewed towards positive experiences and
varied from 75.3 to 78.6 for Finland and Sweden,
respectively. Approximately 10% of the patients in both
of the Norwegian and the Swedish surveys scored 60 or
below. In Finland, 15.7% of Finnish patients scored 58.3
or below, while on the Faroe Islands, 16.3% scored 58.3
or below. Scores for the six items were also similar with
all three countries scoring lowest on the item relating to
information on test and examinations. Finland, Sweden
and the Faroe Islands had the highest scores on the item
relating to nursing care, while Norway had very similar
high scores for this item and two others. Scores for the
satisfaction item were also generally high.
Table 5 shows the results of validity testing. The
correlations across the different surveys are broadly
consistent. High levels of correlations were found
between the NORPEQ scores and general satisfaction in
the range 0.72e0.77 and correlations with incorrect
treatment were lower and in the range 0.24e0.39 for all
surveys. For Finland, Norway and Sweden, correlations
with expectations relating to treatment and care were
moderate and in the range 0.51e0.58. Correlations with
expectations relating to health outcome were lower and
in the range 0.30e0.38. Lower levels of correlation were
found for the health-related variables, for example,
general health had low correlations with NORPEQ
scores in Norway and Sweden, whereas in Finland,
general health did not correlate with NORPEQ. The
health-related variables were not available for the Faroe
Islands.
DISCUSSION AND CONCLUSIONS
Discussion
The NORPEQ is a short self-completed questionnaire
with evidence for data quality, reliability and validity. The
NORPEQ includes what are judged to be the most
important aspects of experiences for patients.
1 Levels of
missing data were very low across the eight items for
Finland, Norway and Sweden. The results of PCA showed
one uniform measure of patient experiences based on
the six NORPEQ items, and general satisfaction and
incorrect treatment are treated as supplementary items.
Overall, this shows that NORPEQ meets the objective to
develop a short questionnaire covering the most
important aspects of patient experiences within the
Nordic countries.
Furthermore, the NORPEQ shows evidence for
construct validity in tests that were based on hypothesised
associations with variables relating to general satisfaction,
incorrect treatment,
9 13 24 health status, health outcomes
and fulﬁlment of expectations.
1 6 18 24 29 However,
although it was negative which followed the hypothesis,
the correlation between general health and the
NORPEQ for the Finnish data was close to zero. The
future inclusion of more speciﬁc questions that relate to
different aspects of health will help determine whether
this ﬁnding has implications for cross-cultural validity.
The testeretest reliability of the NORPEQ has been
found to be acceptable in two Norwegian surveys at the
local and national levels.
13 It would be an advantage to
have testeretest data for the other countries as well.
Previous studies have found comparable results for
internal consistency and testeretest reliability for
measures of patient experiences.
72 4Therefore, it is
reasonable to assume similar levels of testeretest reli-
ability for the other countries given the similarity of the
results across the countries.
Compared with other surveys of patient experiences at
a national level, the samples for the surveys were small
and three of them were pilot studies. However, the
different analyses still produced satisfactory results and
items performed very similarly across the countries.
Mean item scores, component loadings and item-total
correlations were similar across countries. Results of
validity testing were in line with those following national
surveys that have used longer questionnaires comprising
scales relating to different aspects of patient experiences
and satisfaction.
6 30 NORPEQ scores had similar signiﬁ-
cant levels of correlation with those for the additional
Table 3 Component loadings and internal consistency of the NORPEQ
Finland Norway
National
Norway Sweden Faroe
Comp
load
CA/item
total
Comp
load
CA/item
total
Comp
load
CA/item
total
Comp
load
CA/item
total
Comp
load
CA/item
total
NORPEQ score 0.84 e 0.85 0.87 e 0.88 0.87
Doctors understandable 0.74 0.62 0.71 0.59 0.76 0.65 0.80 0.71 0.75 0.64
Doctors’
professional skills
0.76 0.63 0.76 0.63 0.78 0.68 0.73 0.62 0.78 0.68
Nurses’
professional skills
0.70 0.56 0.76 0.64 0.79 0.68 0.79 0.69 0.78 0.66
Nursing care 0.68 0.53 0.73 0.60 0.77 0.65 0.77 0.67 0.75 0.63
Health personnel
interested in problem
0.82 0.71 0.81 0.71 0.83 0.74 0.87 0.80 0.81 0.72
Information on tests 0.80 0.69 0.78 0.66 0.76 0.65 0.80 0.70 0.79 0.69
NORPEQ, Nordic Patient Experiences Questionnaire.
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Cross-national comparison of data quality and validity of the NORPEQ instrumentitems used in validity testing, the exception being
general health for Finland. The strong associations
between patient experiences as measured by NORPEQ
and general satisfaction in each country conﬁrm the
importance of the NORPEQ items as a measure of
patient experiences across countries.
The measurement of patient experiences is an
important component of patients’ evaluation of health-
care services.
1 During the past decade, measures of
patient experiences have gained increasing interest as
healthcare quality indicators. Most studies of healthcare
quality indicators have taken place at the local level, and
few studies have conducted comparisons across coun-
tries.
2 It is thus difﬁcult to know whether variations in
patient experiences reﬂect differences in culture, health
systems or actual differences in quality as perceived by
patients.
31
Methodological concerns aside, existing research has
implied that there is cross-national variation in patient
experiences.
32 The Commonwealth Fund and the WHO
have conducted surveys of the general population
32 33
and within primary care.
34 Recipients of the survey
results have included health ministers and decision-
makers in each of the countries. Commonwealth Fund
surveys include a large number of single items, and
there has been no reporting of data quality, reliability
and validity.
2 The Picker Institute has compared
patients’ perceptions of the quality of acute hospital
care as well as more focused surveys of patient experi-
ences across Germany, Sweden, Switzerland, the UK and
the USA.
11 These studies have focused on results of
surveys and have not described the translation processes
and cross-cultural testing.
2 The Consumer Assessment
of Health Plan Surveys has published the results of one
cross-cultural evaluation of its questionnaires,
35 and it is
translated for use in the Netherlands.
36 However,
Consumer Assessment of Health Plan Surveys ques-
tionnaires have not been used in international
comparisons.
2 Finally, one study used existing data
for 12 European countries in comparisons of the quality
of primary care.
37 However, evidence for the cross-
cultural equivalence of the included instruments was
not given.
The present study is the ﬁrst to report on the necessary
evaluative work to support cross-national comparisons of
patient experiences for several countries. One study
included a cross-national comparison of public trust in
healthcare in Germany, the Netherlands and England
and Wales that has followed guidelines for questionnaire
development including forwardebackward translation
and cross-cultural testing.
38 In contrast to the similar
ranking of patients’ conﬁdence in both nurses’ and
doctors’ skills across the NORPEQ countries, this study
revealed signiﬁcant differences across the countries
when comparing public trust in healthcare providers
including doctors.
37 However, patient experiences and
public trust are different constructs, and the two surveys
of these constructs were undertaken in different popu-
lations. The NORPEQ is the ﬁrst questionnaire devel-
oped to compare general hospital inpatients’
experiences across countries, which is the most studied
and largest group of healthcare users.
Furthermore, patient experiences were assessed in
four countries with highly similar healthcare delivery.
This similarity may have contributed to the consensus in
identifying important aspects of experiences for inclu-
sion in the NORPEQ. The process of item development
included experts from the different countries who
subsequently monitored all phases of the project. The
translation process followed recommended procedures
relating to cross-cultural adaptation within health-
related research.
17 39
The study included two national surveys for Norway
and the Faro Islands, but two surveys of just one
University hospital for two other countries, Finland and
Sweden, which limits the conclusions that can be drawn
in terms of the appropriateness of the NORPEQ and
cross-cultural equivalence. However, the national survey
results for Norway and the Faroe Islands were very
similar to those reported in an earlier study of the
NORPEQ that included patients from one Norwegian
University hospital using the similar survey design that
was reported here for Finland and Sweden. Hence, it is
reasonable to hypothesise that the NORPEQ will
perform similarly in national surveys within these coun-
tries and in other Nordic countries following
Table 5 Correlation of NORPEQ scores with patient perceptions of satisfaction, incorrect treatment, expectations, health and
outcomes
Finland Norwayy National Norway Sweden Faroe Islands
General satisfaction 0.77** 0.74** 0.72** 0.73** 0.73**
Incorrect treatment  0.35**  0.39**  0.39**  0.24**  0.31**
Expectations: treatment and care 0.53** 0.51** 0.57** z 0.58** e
Expectations: outcomes 0.30** 0.32** 0.37** 0.38** e
General health  0.09  0.19**  0.24**  0.24** e
General health compared with before admission e 0.22* 0.27** ee
Physical health compared with before admission e 0.27** 0.22** ee
Statistical signiﬁcance:*p<0.05; ** p<0.01.
yThese results were reported in a previous article.
13
zThis question has a slightly more general wording in the national Norwegian survey than in the other pilots.
26
NORPEQ, Nordic Patient Experiences Questionnaire.
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Cross-national comparison of data quality and validity of the NORPEQ instrumentrecommended translation procedures and cognitive
testing. To further assess the NORPEQ for cross-cultural
equivalence, evaluation following national surveys based
on representative samples including the other Nordic
countries should be conducted. Moreover, the inclusion
of NORPEQ alongside existing instruments used in
national surveys of inpatient experiences or other
patient groups’ experiences will further contribute to
the cross-national evaluation of validity.
Practice implications
This study has demonstrated that it is possible to
cover important aspects of the healthcare experiences
in a short-form measure. Furthermore, the 8-item
questionnaire has proved relatively easy to translate
and evaluate across the Nordic countries. Through
the inclusion of the NORPEQ in national surveys of
Norway and the Faroe Islands, the current study has
shown how the brevity of the questionnaire lends it
feasibility for inclusion as part of existing national
surveys. Hence, we consider the NORPEQ suitable as
a supplement to future national healthcare surveys
conducted in the Nordic countries that can facilitate
cross-national comparisons to inform Nordic citizens,
patients, politicians and leaders and personnel in
healthcare about patient experiences as a measure of
the quality of healthcare. This will promote a mutual
understanding of quality in healthcare across the
Nordic countries.
Conclusions
Although NORPEQ is brief, it measures important
aspects of patient experiences directly related to the care
patients receive in the hospital. Items typically used in
longer questionnaires such as hospital access, hospital
equipment or standards of patient facilities
6 are not
included. Still, results of testing for validity including the
high level of correlation with responses to the general
satisfaction item follow previous ﬁndings for longer
questionnaires.
12 4The strength of NORPEQ is the focus
on important aspects of healthcare summed to form
a single score that is, supplemented with two items
relating to patient perceptions of incorrect treatment
and satisfaction. The NORPEQ is acceptable and feasible
for cross-national comparisons of hospital care but
should also be considered for applications alongside
existing national surveys for the Nordic countries.
30
Overall, the NORPEQ scores show that there is consid-
erable scope for improvement in delivery of care in the
Nordic countries.
To conclude, the NORPEQ has acceptable data quality,
reliability and validity within the Faroese, Finnish,
Norwegian and Swedish inpatients. The questionnaire
has been translated into other Nordic languages,
cognitive interviews have taken place in Denmark and
further testing is planned in Iceland. Following further
evaluation, the NORPEQ will be used in future national
and cross-national surveys. The NORPEQ was developed
and tested as part of a Nordic quality indicator project
that aims to assess and compare health service perfor-
mance across the Nordic countries. Such cross-national
comparisons of health system performance offer greater
accountability and transparency, support strategy review
and development, and give potential for mutual
learning.
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